Pnc Financial Services Group, Inc. Intra Cellular Therapies, Inc. Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 8,391 shares of ITCI stock, worth $719,024. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,391

Previous 7,549 11.15%

Holding current value

$719,024

Previous $517,000 18.57%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$67.99 - $80.84 $57,247 - $68,067	842 Added 11.15%	8,391 $613,000
Q2 2024 Aug 09, 2024	BUY	$64.76 - $79.84 $205,353 - $253,172	3,171 Added 72.43%	7,549 $517,000
Q1 2024 May 10, 2024	BUY	$64.37 - $75.65 $37,527 - $44,103	583 Added 15.36%	4,378 $302,000
Q4 2023 Feb 09, 2024	SELL	$46.37 - $73.65 $11,082 - $17,602	-239 Reduced 5.92%	3,795 $271,000
Q3 2023 Nov 13, 2023	SELL	$52.09 - $64.1 $161,322 - $198,517	-3,097 Reduced 43.43%	4,034 $210,000
Q2 2023 Aug 11, 2023	BUY	$54.67 - $66.44 $50,788 - $61,722	929 Added 14.98%	7,131 $451,000
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $14,322 - $18,635	327 Added 5.57%	6,202 $335,000
Q4 2022 Feb 10, 2023	SELL	$44.07 - $54.45 $34,550 - $42,688	-784 Reduced 11.77%	5,875 $310,000
Q3 2022 Nov 10, 2022	BUY	$42.7 - $59.99 $32,836 - $46,132	769 Added 13.06%	6,659 $309,000
Q2 2022 Aug 12, 2022	SELL	$43.0 - $65.64 $817 - $1,247	-19 Reduced 0.32%	5,890 $336,000
Q1 2022 May 12, 2022	BUY	$38.74 - $62.09 $46,642 - $74,756	1,204 Added 25.59%	5,909 $361,000
Q4 2021 Feb 11, 2022	BUY	$35.2 - $53.42 $51,814 - $78,634	1,472 Added 45.53%	4,705 $246,000
Q3 2021 Nov 05, 2021	BUY	$28.72 - $42.49 $32,654 - $48,311	1,137 Added 54.25%	3,233 $120,000
Q2 2021 Aug 06, 2021	SELL	$29.3 - $44.5 $9,405 - $14,284	-321 Reduced 13.28%	2,096 $85,000
Q1 2021 May 07, 2021	SELL	$30.8 - $39.51 $3,942 - $5,057	-128 Reduced 5.03%	2,417 $82,000
Q3 2020 Nov 06, 2020	BUY	$17.61 - $31.86 $5,652 - $10,227	321 Added 14.43%	2,545 $65,000
Q4 2019 Feb 07, 2020	BUY	$7.26 - $38.49 $1,147 - $6,081	158 Added 7.65%	2,224 $76,000
Q3 2019 Nov 08, 2019	SELL	$7.47 - $14.03 $709 - $1,332	-95 Reduced 4.4%	2,066 $15,000
Q2 2019 Aug 09, 2019	BUY	$10.65 - $14.29 $1,011 - $1,357	95 Added 4.6%	2,161 $0
Q2 2018 Aug 10, 2018	BUY	$17.33 - $23.4 $34,660 - $46,800	2,000 Added 3030.3%	2,066 $0
Q4 2017 Feb 09, 2018	BUY	$14.27 - $16.79 $941 - $1,108	66	66 $0

Others Institutions Holding ITCI

# of Institutions

377

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.09B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Intra Cellular Therapies, Inc. Transaction History